drugset / Trial / NCT00004338

Study of Zinc for Wilson Disease

NCT00004338

Treatment

Summary

OBJECTIVES: I. Establish the safety and efficacy of extended maintenance zinc therapy in 200 patients with Wilson disease. II. Establish further the role of zinc in the prophylactic treatment of presymptomatic patients by increasing the current cohort from 80 to at least 100 patients. III. Establish further the role of zinc therapy in pregnant patients with Wilson disease. IV. Establish further the role of zinc therapy in children with Wilson disease.

Timeline

Start
1993-10
Primary completion
Completion

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown

Indications